Gastric emptying and pancreatic polypeptide response to carbohydrate meals

1985 ◽  
Vol 30 (1) ◽  
pp. 52-57 ◽  
Author(s):  
I. L. Taylor ◽  
P. O. Gulsrud ◽  
J. Elashoff ◽  
P. Chew ◽  
J. H. Meyer
1987 ◽  
Vol 151 (3) ◽  
pp. 275-281 ◽  
Author(s):  
FUMIAKI KOIZUMI ◽  
TAKESHI KAWAMURA ◽  
AKIRA ISHIMORI ◽  
HIROKO EBINA ◽  
MICHINORI SATOH

2000 ◽  
Vol 278 (6) ◽  
pp. G946-G951 ◽  
Author(s):  
Melvin Samsom ◽  
Lawrence A. Szarka ◽  
Michael Camilleri ◽  
Adrian Vella ◽  
Alan R. Zinsmeister ◽  
...  

The amylin analog pramlintide delays gastric emptying in type I diabetics. The effects of multiple doses of pramlintide and the mechanism of action in non-amylin-deficient humans are unknown. We investigated the effects of pramlintide on gastrointestinal and colonic transit and on the plasma pancreatic polypeptide response to the meal in a parallel-group dose-response study with subjects randomized to placebo, or 30 or 60 μg (tid, sc) of pramlintide. Pramlintide delayed gastric emptying [half-time ( t½): 112 min (SE 8.7 min), 169 min (SE 12 min), or 177 min (SE 25 min) after placebo or 30- or 60-μg pramlintide treatment, respectively; P = 0.033]. Pramlintide did not significantly affect small bowel or colonic transit. Pancreatic polypeptide concentrations in the first postprandial hour were lower with pramlintide than with placebo ( P < 0.01 for drug effect). An inverse correlation was observed between mean pancreatic polypeptide concentrations in the first postprandial hour and gastric emptying t½[Spearman correlation coefficient ( Rs) = 0.48; P = 0.044]. Pramlintide at 30 and 60 μg delays gastric emptying in healthy humans without affecting small bowel or colonic transit. Vagal inhibition is a potential mechanism of the effects of pramlintide on gastric emptying.


Peptides ◽  
1996 ◽  
Vol 17 (6) ◽  
pp. 895-900 ◽  
Author(s):  
Hiroyuki Okano ◽  
Akio Inui ◽  
Naohiko Ueno ◽  
Shinsuke Morimoto ◽  
Akiyoshi Ohmoto ◽  
...  

Digestion ◽  
1981 ◽  
Vol 21 (4) ◽  
pp. 214-218 ◽  
Author(s):  
T.E. Adrian ◽  
G.R. Greenberg ◽  
M.L. Fitzpatrick ◽  
S.R. Bloom

2011 ◽  
Vol 140 (5) ◽  
pp. S-305
Author(s):  
Sofie Verschueren ◽  
Pieter Janssen ◽  
Rita Vos ◽  
Kristin Verbeke ◽  
Jan F. Tack

Gut ◽  
1993 ◽  
Vol 34 (2) ◽  
pp. 166-172 ◽  
Author(s):  
G Stacher ◽  
T L Peeters ◽  
H Bergmann ◽  
S Wiesnagrotzki ◽  
C Schneider ◽  
...  

1995 ◽  
Vol 269 (1) ◽  
pp. R167-R172 ◽  
Author(s):  
D. M. McTigue ◽  
C. H. Chen ◽  
R. C. Rogers ◽  
R. L. Stephens

Pancreatic polypeptide (PP) has been shown to alter gastrointestinal functions, including increased gastric acid secretion and motility following brain stem injections of PP. The present study investigated the effect of an intracisternal injection of PP on the rate of gastric emptying. Additionally, the efficacy of the rat and bovine forms of the peptide was compared. Rats anesthetized with ether received an intracisternal injection of rat PP, bovine PP, or vehicle and, upon regaining consciousness, were fed a liquid test "meal." Intracisternal rat PP produced a marked enhancement in gastric emptying compared with control animals. Bovine PP, at doses equimolar to or three times greater than the effective rat PP dose, produced no change in gastric emptying. Pretreatment with systemic atropine prior to central injection of rat PP eliminated the stimulation of emptying, suggesting that PP acts through a cholinergic mechanism. When equimolar doses of rat or bovine PP were microinjected directly into the dorsal vagal complex, the region containing PP receptors, both were capable of stimulating antral motility. The response to bovine PP, however, was delayed and reduced compared with that seen following rat PP. The results suggest that rat PP strongly stimulates gastric emptying in rats and that bovine PP, depending on the route of administration, is either ineffectual or a weaker agonist for central PP receptors.


Sign in / Sign up

Export Citation Format

Share Document